Delivery Order SPE2DB20D3103-SPE2DB25FP4V9
Award Date
7/11/25
Potential Completion Date
7/14/25
Potential Value
$2.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 50 mg/25 ml vials of doxorubicin liposome, a chemotherapy medication, with a ceiling value of $2,255.13 and a period of performance through July 7, 2025. The contract is designated as a firm-fixed-price delivery order, with no set-aside, indicating open competition....
This is a $3,404.64 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for 50mg/25ml vials of the drug doxorubicin liposome, a chemotherapy medication. The award has a completion date of July 7, 2025 and is not designated as a set-aside contract, indicating open competition. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract...
This federal contract award is a delivery order (SPE2DB20D3103|SPE2DB24FM4V2) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4563493004 - Doxorubicin Liposome 50mg/25ml 25ml. The $1,500.00 firm fixed price award was made by the Defense Logistics Agency (DLA) on January 30, 2024, with a completion date of January 31, 2024. The contract does not have a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $5,400.00 fixed-price delivery order is for the supply of 4,564,081,943 units of Doxorubicin Liposome 20mg/10ml 10ml, a specialty pharmaceutical product, with a performance period through March 27, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract worth $1,726.81 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 50 mg Doxorubicin vials. This Delivery Order contract is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical...
The Defense Logistics Agency (DLA) awarded a $1,691.20 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4564010703 ! DOXIL 20 MG/10 ML VIAL 10ML. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as Amerisourcebergen's primary contract vehicle to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price, with a ceiling value of $2,254.32 and a completion date of June 20, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price of $3,376.40 and an ultimate completion date of July 2, 2025. It was awarded by the Defense Logistics Agency (DLA), which is the Department of Defense's combat logistics support agency. The contract provides for the supply of a range of pharmaceutical products and medical supplies to support military healthcare...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of a range of pharmaceutical products and medical supplies. The contract has a ceiling value of $4,994.30 and a completion date of June 17, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $13,788.50 and a completion date of June 24, 2025. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a...